RIBOFLAVIN 5^-PHOSPHATE ANHYDROUS: 20 Adverse Event Reports & Safety Profile
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
20
Total FAERS Reports
15 (75.0%)
Deaths Reported
18
Hospitalizations
20
As Primary/Secondary Suspect
14
Life-Threatening
15
Disabilities
Active Ingredient: RIBOFLAVIN 5^-PHOSPHATE SODIUM ANHYDROUS ·
First Report: 20190624 · Latest Report: 20200601
What Are the Most Common RIBOFLAVIN 5^-PHOSPHATE ANHYDROUS Side Effects?
#1 Most Reported
Off label use
6 reports (30.0%)
#2 Most Reported
Swelling
5 reports (25.0%)
#3 Most Reported
Sleep disorder
5 reports (25.0%)
All RIBOFLAVIN 5^-PHOSPHATE ANHYDROUS Side Effects by Frequency
| Side Effect | Reports | % of Total | Deaths | Hosp. |
|---|---|---|---|---|
| Off label use | 6 | 30.0% | 5 | 6 |
| Drug hypersensitivity | 5 | 25.0% | 5 | 5 |
| Dyspnoea | 5 | 25.0% | 5 | 5 |
| Incorrect route of product administration | 5 | 25.0% | 4 | 5 |
| Sleep disorder | 5 | 25.0% | 5 | 5 |
| Swelling | 5 | 25.0% | 5 | 5 |
Who Reports RIBOFLAVIN 5^-PHOSPHATE ANHYDROUS Side Effects? Age & Gender Data
Gender: 19.0% female, 81.0% male. Average age: 76.4 years. Most reports from: CA. View detailed demographics →
Is RIBOFLAVIN 5^-PHOSPHATE ANHYDROUS Getting Safer? Reports by Year
| Year | Reports | Deaths | Hosp. |
|---|---|---|---|
| 2019 | 1 | 0 | 1 |
| 2020 | 7 | 7 | 7 |
What Is RIBOFLAVIN 5^-PHOSPHATE ANHYDROUS Used For?
| Indication | Reports |
|---|---|
| Constipation | 13 |
Official FDA Label for RIBOFLAVIN 5^-PHOSPHATE ANHYDROUS
Official prescribing information from the FDA-approved drug label.